CLEVELAND , June 3, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today grants of stock options and restricted stock units to Zach Stassen , Chief Financial Officer for the company. These awards were granted as an inducement material to entering into employment with ViewRay , in
CLEVELAND , May 28, 2020 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will present at the Jefferies 2020 Virtual Healthcare Conference . Scott Drake , President and CEO, will participate in a fireside chat at 2:30 p.m. Eastern Time on Tuesday, June 2, 2020 .
First MR-Linac in the Pacific Northwest Expands Cancer Patients' Access to MR-Guided Radiation Therapy CLEVELAND , May 27, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Providence Portland Medical Center in Portland, Oregon has begun patient treatments with the MRIdian®
CLEVELAND , April 30, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Zach Stassen has been named Chief Financial Officer, effective May 18, 2020 . Mr. Stassen will report directly to Scott Drake , President and Chief Executive Officer. Mr.
CLEVELAND , April 30, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the first quarter ended March 31, 2020 . First Quarter 2020 Highlights: Total revenue of $14.3 million , primarily from three revenue units including one system upgrade, compared to $20.3
CLEVELAND , April 16, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced the appointment of B. Kristine Johnson to its Board of Directors effective April 14, 2020 . Ms. Johnson brings a wealth of health care and medical technology knowledge, as well as broad experience in finance and
CLEVELAND , April 9, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its first quarter 2020 financial results. ViewRay will hold a conference call to discuss results on Thursday, April 30, 2020 at 4:30 p.m. ET / 1:30 p.m. PT .
Collaboration offers clinicians a personalized oncology solution that combines cutting-edge MRI-guided radiation therapy with a leading AI-driven EMR integration platform CLEVELAND , April 1, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today a strategic collaboration with VieCure,
System Order Will Bring the Benefits of MRI-guidance and On-table Adaptive Therapy to Patients Throughout the Region CLEVELAND , March 19, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Enloe Medical Center – an independent, nonprofit hospital in Chico , California– has
First Treatments at Munich Hospital Leverage MRIdian's Precision for High-Dose Delivery and Adaptive Therapy Capabilities CLEVELAND , March 18, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Ludwig-Maximilians-University Hospital in Munich has begun patient treatments with
CLEVELAND , March 12, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the fourth quarter and full year ended December 31, 2019 . A supplemental presentation for today's conference call is included on the Company's website at
CLEVELAND , Feb. 13, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its fourth quarter and full year 2019 financial results. ViewRay will hold a conference call to discuss results on Thursday, March 12, 2020 at 4:30 p.m. ET / 1:30 p.m. PT .
CLEVELAND , Jan. 13, 2020 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced preliminary results for the fourth quarter and full fiscal year ended December 31, 2019 . The preliminary results have not been audited and are subject to change. Selected Fourth Quarter and Full Year 2019
